Krishna Institute of Medical Sciences Ltd.
NSE: KIMS · Healthcare
Accelerating earnings deterioration (Q1 FY27 PAT down 47.2% YoY) and unresolved leverage concerns outweigh bullish technicals lacking…
Bullish EMA stack with 5.23% premium to 200-day MA and 13.65% relative outperformance over 12 months suggest structural market preference, supported by confirmed 28.2% FY26 revenue growth and asset-light O&M expansion strategy.
Net profit collapsed 47.2% in Q1 FY27 (worse than FY26's 41.7% decline), promoter pledge of 6.66% stake signals leverage stress, and 72% volume conviction is insufficient to sustain upside if earnings disappoint further.
Free: 5 Forecasts and 5 Debates a month. Log in with your mobile number.
-
Bearish 28 Sep 2026 → now Scores 28 Oct 2026₹766.45 → ₹766.45 0.0%
Every verdict and forecast here is dated and scored when it matures — right or wrong. The first scored results publish a month after launch.
How we score →
Bullzeye Financial